# Olive Medicine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/olive-medicine

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Total disclosed funding: $2.2M
- Latest round: Angel (Aug 17, 2020)
- Investors on record: 1

## About

Established in 2019 and based in Shenzhen, China, Olive Medicine operates as a medical company that focuses on the research and development of small-molecule drug therapy. In August 2020, Olive Medicine raised an angel funding for CNY 15 million from new investor Junsan Capital.

Olive Medicine's main business is the research and development of small-molecule drug therapy. Its developed small-molecule drugs are based on traditional Chinese Medicine (TCM) and natural plants, with preventive and curative potentials. Products can be used in the treatment of diseases such as aging and related metabolic disorders.

## Funding rounds

- Angel, Aug 17, 2020, $2.2M — Junsan Capital

## Investors

- Junsan Capital (https://capitalatlas.ai/funds/junsan-capital) — Angel